Stock Price Quote

AURO LABORATORIES LTD.

NSE : NABSE : 530233ISIN CODE : INE292C01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE201.95-1.35 (-0.66 %)
PREV CLOSE ( ) 203.30
OPEN PRICE ( ) 205.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16287
TODAY'S LOW / HIGH ( )195.00 209.70
52 WK LOW / HIGH ( ) 63209.7
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1989
Management Info
Sharat Deorah - Chairman Sharat Deorah - Managing Director
Registered Office

Address K 56 M I D C Industrial Area,Boisar,Tarapur,
Palghar,
Maharashtra-401506

Phone 022- 56635456

Email auro@aurolabs.com

Website www.aurolabs.com

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE

NEWS

22Mar Auro Laboratories informs about disclo
Auro Laboratories has informed about disclosure under Regulation 29(2) o..
06Mar Auro Laboratories informs about loss o
Auro Laboratories has informed that share certificates have been reporte..
25Jan Auro Laboratories inks pact with MIDC
Auro Laboratories has entered into an Agreement with Maharashtra Industr..
25Jan Auro Laboratories touches roof on inki
Auro Laboratories is currently trading at upper limit of Rs. 130.60, up..
24Aug Auro Laboratories zooms on getting nod
Auro Laboratories is currently trading at Rs. 93.57, up by 10.87 points..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit27.3424.41
Gross Profit 37.88 34.45
Operating Profit 45.0353.33
Net Sales 179.78528.94

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  2621.00 (5.75%)
M.Cap ( in Cr)1619.26
Glaxosmithkline Phar (BSE)
peergroup  2079.80 (7.06%)
M.Cap ( in Cr)35233.07
TTK Healthcare (BSE)
peergroup  1591.35 (5.77%)
M.Cap ( in Cr)2248.63
Cipla (BSE)
peergroup  1398.80 (3.79%)
M.Cap ( in Cr)112938.41
Torrent Pharma (BSE)
peergroup  2685.00 (1.85%)
M.Cap ( in Cr)90872.60

Shareholding Pattern

PROMOTERS 52.15%
NON-INSTITUTION 47.84%
MUTUAL FUNDS/UTI 0.01%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Auro Laboratories Ltd.

Auro Laboratories Ltd. was incorporated in the year 1989. Its today's share price is 201.95. Its current market capitalisation stands at Rs 125.87 Cr. In the latest quarter, company has reported Gross Sales of Rs. 528.94 Cr and Total Income of Rs.538.36 Cr. The company's management includes Sweta Agarwal, Govardhan Das Agarwal, Kavita Vijayakant Sharma, Kiran Kulkarni, Siddhartha Deorah, Sharat Deorah, Sharat Deorah.

It is listed on the BSE with a BSE Code of 530233 , NSE with an NSE Symbol of and ISIN of INE292C01011. It's Registered office is at K 56 M I D C Industrial Area,Boisar,TarapurPalghar-401506, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Khurdia Jain & Co, Kothari Jain & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.